Transparency Market Research, a global market intelligence
consultancy, has published a market study on the global
transcriptomics technologies market for the 2013-2019 period.
According to this report, the global transcriptomics technologies
market will rise at a CAGR of 15.90% from 2013 to 2019 to reach a
valuation of US$4.6 bn by the end of the forecast period. The
market’s valuation in 2012 was US$1.65 bn. The report is titled
“Transcriptomics Technologies Market - Global Industry Analysis,
Size, Share, Growth, Trends and Forecast, 2013 - 2019”.
Report Overview @
https://www.transparencymarketresearch.com/transcriptomics-technologies-market.html
The report says that the global transcriptomics technologies market
will witness substantial growth in the coming years due to several
reasons. Transcriptomics research involves studying the structure and
function of RNA present in a cell.Presently, transcriptome analysis
of several organisms is assisted using next-generation sequencing
platforms in the preliminary phase followed by polymerase chain
reactions, gene regulation technologies, and microarrays in the
latter part. The coalition of these technologies is used for drug
discovery, clinical diagnosis of diseases, medical research, and
others. With the ever-increasing demand for targeted therapeutics and
continual improvement of healthcare infrastructure, the commercial
usage of transcriptomics technologies holds promise. Transcriptomics
research allows the development of newer therapeutics and diagnostics
and further advancement of the existing line of treatment for medical
conditions.
The report says that in the transcriptomics technologies market, the
key application segments undergo consistent development in order to
offer added value to users. For instance, the utilization of
transcriptomics technologies has benefitted the pharmaceutical and
biotechnology fields; other fields are also deriving the advantages
of this technology for mutual benefits of both the technology and the
application field. Laboratories attempting to use biomarkers and
newer gene sequencing methods is an example of this.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1659
The need for the development of adequate equipment in healthcare
organizations and laboratories, the growing awareness about
transcriptomics technologies globally, and increased participation of
government bodies in transcriptomics research are some other factors
driving this global market.
However, growth of the transcriptomics technologies market is
hampered due to certain factors cited in this report. These include
the unavailability of advanced equipment needed for biological
computation, unavailability of services essential to analyzing
complex information, and an overall deficit of technicians that have
expertise in the subject.
The report divides the global transcriptomics technologies market
into the regional segments of North America, Asia Pacific, Europe,
and Rest of the World. Among the regional segments, Asia Pacific will
exhibit a substantial uptake of these technologies and the fastest
growth rate in the transcriptomics technologies market during the
forecast period. Ongoing infrastructural development for improved
healthcare and increased acceptance of novel biotechnology research
are the reasons for this.
In 2012, North America led the global transcriptomics technologies
market, contributing more than 35% of the revenue in the global
market. The presence of advanced healthcare infrastructure, which
includes well-equipped research facilities, increased awareness of
biotechnology research, and the high number of initiatives taken by
governments to promote research activities are the reasons for the
dominant position of North America in this market.
Purchase this Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=1659<ype=S
The report mentions the top players that operate in the global
transcriptomics market. These are Life Technologies Corporation,
F-Hoffmann La Roche Ltd., Thermo Fisher Scientific, Illumina Inc.,
Agilent Technologies, and Affymetrix Inc.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment